In Vitro Activity of Ceftazidime-Avibactam against 3rd Generation Cephalosporin and Carbapenem Resistant Gram-Negative Bacteria Obtained from Blood and Fecal Samples of Hematopoietic Stem Cell Transplanted Patients
Acta Microbiologica Bulgarica · 2023
DOI: 10.59393/amb23390111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica Bulgarica, 2023. Verfasst von D. Niyazi und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The recipients of hematopoietic stem cell transplantation (HSCT) tend to develop invasive infections because of the immunosuppression caused by the underlying disease or the transplantation itself. The gastro¬intestinal tract is the major source of causative agents, often demonstrating multidrug resistance. The aim of this study is to investigate the in vitro activity of ceftazidime-avibactam (CZA) against 3rd generation ceph¬alosporin and/or carbapenem resistant (CPR) Gram-negative bacteria obtained from blood and fecal sam¬ples of patients following HSCT. Thirty-five clinical isolates were studied (Enterobacterales, n=25, Pseu-domanas spp., n=8, A. baumannii, n=2). MALDI Biotyper (Bruker) and Phoenix system (BD) were used for identification and susceptibility testing. Multiplex PCR was performed to detect genes associated with beta-lactam resistance. In the studied group 96% of the enteric bacteria were Extended Spectrum Beta Lacta¬mase producers (ESBL) and all were susceptible to CZA. CZA demonstrated an excellent activity against piperacillin-tazobactam resistant isolates. Among the CPR isolates, 91% were CZA resistant and blaVIM, blaOXA-23 and blaOXA-24/40, blaOXA-48 genes were detected. In conclusion, an excellent activity of CZA against ESBL producing and piperacillin-tazobactam resistant Gram - negative isolates was found. Despite its potent activity against class A enzymes, avibactam failed to inactivate class B and class D carbapenemases.
Zitieren
APA
Niyazi, D., & Stoeva, T. (2023). In Vitro Activity of Ceftazidime-Avibactam against 3rd Generation Cephalosporin and Carbapenem Resistant Gram-Negative Bacteria Obtained from Blood and Fecal Samples of Hematopoietic Stem Cell Transplanted Patients. Acta Microbiologica Bulgarica. https://doi.org/10.59393/amb23390111
Vancouver
Niyazi D, Stoeva T. In Vitro Activity of Ceftazidime-Avibactam against 3rd Generation Cephalosporin and Carbapenem Resistant Gram-Negative Bacteria Obtained from Blood and Fecal Samples of Hematopoietic Stem Cell Transplanted Patients. Acta Microbiologica Bulgarica. 2023. doi:10.59393/amb23390111
BibTeX
@article{Niyazi2023,
author = {Niyazi, D. and Stoeva, T.},
title = {In Vitro Activity of Ceftazidime-Avibactam against 3rd Generation Cephalosporin and Carbapenem Resistant Gram-Negative Bacteria Obtained from Blood and Fecal Samples of Hematopoietic Stem Cell Transplanted Patients},
journal = {Acta Microbiologica Bulgarica},
year = {2023},
doi = {10.59393/amb23390111}
}
EUVIMED